Sentante successfully completed a GLP study!

Our animal study exceeded expectations and showcased extraordinary results. This milestone marks an important step forward in our journey.

We want to say a heartfelt thank you to all amazing people in Veranex for their incredible expertise and unwavering support during the study. Also, to Lorenzo Patrone, Konstantinos Stavroulakis, Max Amor, Arturas Mackevicius and Giovanni F. Torsello! Your participation and invaluable feedback were instrumental in making this study a success.


Sentante Secures €6 Million in New Funding to Revolutionize Endovascular Care

Sentante announces the closing of a €6 Million seed funding round led by Practica Capital with participation of EIC fund. The company will use the proceeds from the financing for the planned clinical trial of the Sentante robotic system and preparation of commercial launch in targeted international markets.

Read more here.


 Dr. Ricardo A. Hanel has joined our Medical Advisory Board!

Thrilled to announce that Ricardo Hanel has joined our Medical Advisory Board! With over two decades of experience in shaping endovascular neurosurgery, Dr. Hanel brings his knowledge in stroke treatment and other cerebrovascular conditions where fast access to excellent care is critical.

Dr. Hanel’s extensive experience in neurosurgical research and robotics further strengthens our dedication to pioneering remote patient care.

Honored to have his presence on the Sentante team!


Paris Vascular Insights Symposium, 2023

Paris Vascular Insights Symposium #PVI2023 took center stage at the same venue as Paris Fashion Week! 🌟

While the runway dazzled with style, our very own Tomas Baltrunas rocked the stage presenting Sentante, proving that innovation and fashion can share the spotlight!


 MedTech Innovator, California, 2023

Absolutely thrilled to participate in MedTech Innovator, the world’s largest accelerator of medical technology companies and the premier nonprofit startup accelerator in the medical technology industry.

With Sentante, our mission aligns perfectly with their goal of transforming healthcare and improve patients’ lives.



XIII-International-Conference of the Polish Society for Vascular Surgery, Warsaw, 2023

🌊 Riding the Innovation Wave at #PTCHN2023!

Tomas Baltrunas presented Sentante at the prestigious XIII-International-Conference of the Polish Society for Vascular Surgery in Warsaw, Poland.

Huge thanks to all the amazing individuals who made this event possible, and heartfelt gratitude for the priceless feedback we’ve received.



Society of Robotic Surgery | SRS annual meeting, 2023

Proud moment at Society of Robotic Surgery | SRS annual meeting!

Tomas Baltrunas took the stage to present Sentante unveiling some of the most remarkable features that set it apart from any other robotic system in the market:

👌Haptic feedback: Sentante allows users to experience a sense of touch and precision while performing delicate endovascular procedures remotely.

💡Very intuitive interface: even novice users can quickly familiarize themselves with the system, minimizing the learning curve and maximizing productivity.

⏳Straightforward workflow: with a seamless connection between the operator and the robotic system, procedures are performed with ease, saving valuable time during critical interventions.

Thank you Vipul Patel, M.D., F.A.C.S. and Adnan Siddiqui, MD, PhD, FACS, FAHA, FAANS for the invitation. Participating in such an event was truly an honor.


 ICCA Stroke Conference, 2023

Sentante presented at ICCA Stroke Conference, 2023 – thrilling!

ICCA Stroke brought together leading minds in the field to discuss groundbreaking advancements in stroke research and treatment.

🎯All united by a common goal: to improve stroke care and outcomes.

During the presentation, Tomas Baltrunas had the opportunity to dive into the finer details of how Sentante works, the early trial results, and its potential benefits for patients.

The future of stroke care looks bright, and we can’t wait to work with the medical community to bring Sentante to hospitals around the world.



MedTech Innovator Startup Showcase 2023, San Francisco

🌉 San Francisco – the perfect meeting point for groundbreaking ideas and transformative collaborations!

We are happy to share that we’ve landed ourselves a spot in the MedTech Innovator Startup Showcase 2023 in sunny San Francisco, where we had the chance to engage in partnering sessions and connect with other exciting companies in the field.

We’ve been recognized as one of the top startup in the industry and secured our place in the prestigious 2023 Cohort.

❗Interesting fact: Q1 of 2023, alumni companies raised 30% of the total investments in the #medtech startups.

We’re ready to bring our unique spark to the world of medical technology and make a lasting impact with Sentante!


Christopher Prentice has joined our Business Advisory Board!

We are excited to announce that Christopher Prentice has joined our business advisory board!

With over 20 years of exceptional experience in both well-established multinational companies and startups, Christopher brings a wealth of knowledge in advancing new technologies in the field of medical robotics.

Previously, Christopher held the position of Chief Commercial Officer at Mazor Robotics Ltd. (acquired by Medtronic) while also leading the U.S. subsidiary (Mazor Robotics Inc.) as the CEO.
Prior to joining Mazor, he held leadership positions in sales, marketing, and finance at Ethicon Endo-Surgery, a Johnson & Johnson company, Intuitive Surgical, Inc., and Tampa General Hospital.

We are honored to have Christopher on our business advisory board, and we eagerly anticipate the invaluable insights and guidance he will provide to our company.